Thomas E. Hughes's most recent trade in Viridian Therapeutics Inc was a trade of 24,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 21, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Viridian Therapeutics Inc | Thomas E. Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 24,000 | 24,000 | - | - | Stock Option (right to buy) |